ID: ALA3275457

Max Phase: Preclinical

Molecular Formula: C12H19NO3

Molecular Weight: 225.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)NCC(C)(O)c1ccc(O)c(O)c1

Standard InChI:  InChI=1S/C12H19NO3/c1-8(2)13-7-12(3,16)9-4-5-10(14)11(15)6-9/h4-6,8,13-16H,7H2,1-3H3

Standard InChI Key:  ISMURLINKPBPNT-UHFFFAOYSA-N

Associated Targets(non-human)

Beta-2 adrenergic receptor 1382 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-1 adrenergic receptor 895 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 225.29Molecular Weight (Monoisotopic): 225.1365AlogP: 1.30#Rotatable Bonds: 4
Polar Surface Area: 72.72Molecular Species: BASEHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.93CX Basic pKa: 8.99CX LogP: 0.43CX LogD: -0.82
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.58Np Likeness Score: 0.49

References

1. Jen T, Frazee JS, Schwartz MS, Erhard KF, Kaiser C..  (1977)  Adrenergic agents. 8.1 Synthesis and beta-adrenergic agonist activity of some 3-tert-butylamino-2-(substituted phenyl)-1-propanols.,  20  (10): [PMID:20504] [10.1021/jm00220a007]

Source